UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Highly Efficient Perovskite‐Based Electrocatalysts for Water Oxidation in Acidic Environments: A Mini Review

Advanced energy materials, 2021-07, Vol.11 (27), p.n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

“Brain‐Coral‐Like” Mesoporous Hollow CoS2@N‐Doped Graphitic Carbon Nanoshells as Efficient Sulfur Reservoirs for Lithium–Sulfur Batteries

Advanced functional materials, 2019-09, Vol.29 (38), p.n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Porous Lithiophilic Li–Si Alloy‐Type Interfacial Framework via Self‐Discharge Mechanism for Stable Lithium Metal Anode with Superior Rate

Advanced energy materials, 2021-10, Vol.11 (37), p.n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer

The New England journal of medicine, 2020-11, Vol.383 (21), p.2018-2029

2020

Link zum Volltext

Verfügbarkeit prüfen

3D Architectures of Quaternary Co‐Ni‐S‐P/Graphene Hybrids as Highly Active and Stable Bifunctional Electrocatalysts for Overall Water Splitting

Advanced energy materials, 2018-11, Vol.8 (33), p.n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Synergistic Design of Multifunctional Interfacial Zn Host toward Practical Zn Metal Batteries

Advanced energy materials, 2022-12, Vol.12 (48), p.n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer

The New England journal of medicine, 2015-04, Vol.372 (18), p.1689-1699

2015

Link zum Volltext

Verfügbarkeit prüfen

Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer

The New England journal of medicine, 2017-08, Vol.377 (9), p.829-838

2017

Link zum Volltext

Verfügbarkeit prüfen

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

The New England journal of medicine, 2014-12, Vol.371 (23), p.2167-2177

2014

Link zum Volltext

Verfügbarkeit prüfen

In Situ Conversion of Metal–Organic Frameworks into VO2–V3S4 Heterocatalyst Embedded Layered Porous Carbon as an “All‐in‐One” Host for Lithium–Sulfur Batteries

Small (Weinheim an der Bergstrasse, Germany), 2020-11, Vol.16 (47), p.n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

The Lancet (British edition), 2016-04, Vol.387 (10027), p.1540-1550

2016

Link zum Volltext

Verfügbarkeit prüfen

Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment

Scientific reports, 2021-10, Vol.11 (1), p.19712-11, Article 19712

2021

Link zum Volltext

Verfügbarkeit prüfen

Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer

The New England journal of medicine, 2014-03, Vol.370 (13), p.1189-1197

2014

Link zum Volltext

Verfügbarkeit prüfen

Cobalt phosphide nanoarrays with crystalline-amorphous hybrid phase for hydrogen production in universal-pH

Nano research, 2020-09, Vol.13 (9), p.2469-2477

2020

Link zum Volltext

Verfügbarkeit prüfen

Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody

Cancer Immunology, Immunotherapy, 2018-03, Vol.67 (3), p.459-470

2018

Link zum Volltext

Verfügbarkeit prüfen

Elucidating the Synergistic Behavior of Orientation‐Controlled SnS Nanoplates and Carbon Layers for High‐Performance Lithium‐ and Sodium‐Ion Batteries

Advanced energy materials, 2022-02, Vol.12 (8), p.n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2018-08, Vol.36 (22), p.2251-2258

2018

Link zum Volltext

Verfügbarkeit prüfen

Waste Windshield-Derived Silicon/Carbon Nanocomposites as High-Performance Lithium-Ion Battery Anodes

Scientific reports, 2018-01, Vol.8 (1), p.960-12, Article 960

2018

Link zum Volltext

Verfügbarkeit prüfen

Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component

Journal of clinical oncology, 2017-04, Vol.35 (12), p.1288-1296

2017

Link zum Volltext

Verfügbarkeit prüfen

Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2018-03, Vol.36 (9), p.841-849

2018

Link zum Volltext

Verfügbarkeit prüfen

Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors

BMC cancer, 2019-01, Vol.19 (1), p.19-19, Article 19

2019

Link zum Volltext

Verfügbarkeit prüfen

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

Journal of clinical oncology, 2020-11, Vol.38 (31), p.3592-3603

2020

Link zum Volltext

Verfügbarkeit prüfen

3D Architectures of CoxP Using Silk Fibroin Scaffolds: An Active and Stable Electrocatalyst for Hydrogen Generation in Acidic and Alkaline Media

Small (Weinheim an der Bergstrasse, Germany), 2018-06, Vol.14 (25), p.n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.683

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.439)
Mit Volltextzugriff
(2.587)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Highly Efficient Perovskite‐Based Electrocatalysts for Water Oxidation in Acidic Environments: A Mini Review

“Brain‐Coral‐Like” Mesoporous Hollow CoS2@N‐Doped Graphitic Carbon Nanoshells as Efficient Sulfur Reservoirs for Lithium–Sulfur Batteries

Porous Lithiophilic Li–Si Alloy‐Type Interfacial Framework via Self‐Discharge Mechanism for Stable Lithium Metal Anode with Superior Rate

First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer

3D Architectures of Quaternary Co‐Ni‐S‐P/Graphene Hybrids as Highly Active and Stable Bifunctional Electrocatalysts for Overall Water Splitting

Synergistic Design of Multifunctional Interfacial Zn Host toward Practical Zn Metal Batteries

AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer

Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

In Situ Conversion of Metal–Organic Frameworks into VO2–V3S4 Heterocatalyst Embedded Layered Porous Carbon as an “All‐in‐One” Host for Lithium–Sulfur Batteries

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study

Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment

Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer

Cobalt phosphide nanoarrays with crystalline-amorphous hybrid phase for hydrogen production in universal-pH

Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody

Elucidating the Synergistic Behavior of Orientation‐Controlled SnS Nanoplates and Carbon Layers for High‐Performance Lithium‐ and Sodium‐Ion Batteries

Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung Cancer

Waste Windshield-Derived Silicon/Carbon Nanocomposites as High-Performance Lithium-Ion Battery Anodes

Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component

Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer

Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

3D Architectures of CoxP Using Silk Fibroin Scaffolds: An Active and Stable Electrocatalyst for Hydrogen Generation in Acidic and Alkaline Media

Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study

Suchergebnisse filtern